Biotoxtech Statistics

Total Valuation

Biotoxtech has a market cap or net worth of KRW 52.19 billion. The enterprise value is 77.98 billion.

Market Cap	52.19B
Enterprise Value	77.98B

Important Dates

The next estimated earnings date is Thursday, March 20, 2025.

Earnings Date	Mar 20, 2025
Ex-Dividend Date	n/a

Share Statistics

Biotoxtech has 15.72 million shares outstanding. The number of shares has increased by 5.31% in one year.

Current Share Class	n/a
Shares Outstanding	15.72M
Shares Change (YoY)	+5.31%
Shares Change (QoQ)	-0.56%
Owned by Insiders (%)	14.74%
Owned by Institutions (%)	0.18%
Float	10.51M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.37
PB Ratio	1.13
P/TBV Ratio	1.17
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-17.68
EV / Sales	2.03
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-6.75

Financial Position

The company has a current ratio of 0.74, with a Debt / Equity ratio of 1.68.

Current Ratio	0.74
Quick Ratio	0.46
Debt / Equity	1.68
Debt / EBITDA	n/a
Debt / FCF	-5.63
Interest Coverage	-2.07

Financial Efficiency

Return on equity (ROE) is -22.48% and return on invested capital (ROIC) is -5.96%.

Return on Equity (ROE)	-22.48%
Return on Assets (ROA)	-4.49%
Return on Capital (ROIC)	-5.96%
Revenue Per Employee	194.16M
Profits Per Employee	-22.27M
Employee Count	198
Asset Turnover	0.28
Inventory Turnover	2.54

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -44.20% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-44.20%
50-Day Moving Average	3,651.50
200-Day Moving Average	4,812.13
Relative Strength Index (RSI)	47.33
Average Volume (20 Days)	31,434

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Biotoxtech had revenue of KRW 38.44 billion and -4.41 billion in losses. Loss per share was -301.72.

Revenue	38.44B
Gross Profit	1.43B
Operating Income	-9.97B
Pretax Income	-11.53B
Net Income	-4.41B
EBITDA	-5.96B
EBIT	-9.97B
Loss Per Share	-301.72

Full Income Statement

Balance Sheet

The company has 31.53 billion in cash and 65.04 billion in debt, giving a net cash position of -33.51 billion or -2,131.59 per share.

Cash & Cash Equivalents	31.53B
Total Debt	65.04B
Net Cash	-33.51B
Net Cash Per Share	-2,131.59
Equity (Book Value)	38.63B
Book Value Per Share	2,948.57
Working Capital	-22.75B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -11.61 billion and capital expenditures 57.06 million, giving a free cash flow of -11.55 billion.

Operating Cash Flow	-11.61B
Capital Expenditures	57.06M
Free Cash Flow	-11.55B
FCF Per Share	-734.85

Full Cash Flow Statement

Margins

Gross margin is 3.71%, with operating and profit margins of -25.94% and -11.47%.

Gross Margin	3.71%
Operating Margin	-25.94%
Pretax Margin	-29.98%
Profit Margin	-11.47%
EBITDA Margin	-15.50%
EBIT Margin	-25.94%
FCF Margin	n/a

Dividends & Yields

Biotoxtech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.31%
Shareholder Yield	-5.31%
Earnings Yield	-9.09%
FCF Yield	-22.13%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Biotoxtech has an Altman Z-Score of 0.37. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.37
Piotroski F-Score	n/a